Skip to main content

About 6.7 Million Americans Older Than 20 Years Have Heart Failure

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 3, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Oct. 2, 2024 -- About 6.7 million Americans older than age 20 years have heart failure, according to an updated report from the Heart Failure Society of America published online Sept. 24 in the Journal of Cardiac Failure.

Biykem Bozkurt, M.D., Ph.D., from the Baylor College of Medicine in Houston, and colleagues updated trends in the incidence, prevalence, lifetime risk, mortality, and hospitalization rates of heart failure.

The authors note that about 6.7 million Americans older than age 20 years have heart failure, and the prevalence is expected to increase to 8.7, 10.3, and 11.4 million in 2030, 2040, and 2050, respectively. The lifetime risk for heart failure has increased to 24 percent. Compared with the proportion of older patients, the proportion of younger patients with heart failure is increasing. About one-third of U.S. adults are at risk for heart failure, and 24 to 34 percent of the U.S. population has pre-heart failure. Individuals with obesity, hypertension, and clusters of comorbidities have an increased risk for developing heart failure. Compared with other racial and ethnic groups, Black individuals have a higher incidence and prevalence of heart failure. Since 2012, heart failure mortality rates have been increasing, with a more pronounced acceleration since 2020 to 2021. Compared with 1999, the age-adjusted heart failure mortality rates were higher in 2021; in 2021, heart failure accounted for 45 percent of cardiovascular deaths in the United States.

"We need to address worsening trends in heart failure, not only through medical interventions and properly implemented guideline-directed medical therapy, but by tackling the growing challenges in health care regarding access and coverage for appropriate and timely care," Bozkurt said in a statement.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

One in 14 Hospitalized Patients Face Harmful Diagnostic Errors

THURSDAY, Oct. 3, 2024 -- Harmful diagnostic errors (DEs) occur in an estimated one of every 14 hospitalized general medicine patients, according to a study published online Oct...

Prostatic Artery Embolization Offers Lasting Benefit for BPH

THURSDAY, Oct. 3, 2024 -- For men with benign prostatic hyperplasia (BPH), prostatic artery embolization (PAE) is safe and effective over 24 months of follow-up, according to a...

AAP: Disparities Seen in Infant Mortality Rate for Congenital Heart Disease

THURSDAY, Oct. 3, 2024 -- The infant mortality rate from congenital heart disease (CHD) declined significantly for White, but not Black, infants in the United States from 2005 to...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.